Table 1.
BC cell lines panel.
Cell Line | Origin | Stage | Histologic Subtype | Sex | Age | Site of Sampling | P/M | Refs |
---|---|---|---|---|---|---|---|---|
BT-474 | breast ductal carcinoma | invasive | ductal | f | 60 | breast | P | [17] |
CAL-120 | breast adenocarcinoma | invasive | na | f | 43 | PE | M | * |
CAL-148 | breast adenocarcinoma | invasive | ductal | f | 58 | PE | M | [18] |
CAL-51 | breast adenocarcinoma | invasive | ductal | f | 45 | PE | M | [19] |
CAL-85-1 | breast adenocarcinoma | invasive | ductal | f | 35 | breast | M | [18] |
COLO-824 | breast carcinoma | invasive | na | f | 52 | PE | M | * |
DU-4475 | breast ductal carcinoma | invasive | ductal | f | 62 | skin | M | [20] |
EFM-19 | breast ductal carcinoma | invasive | ductal | f | 50 | PE | M | [21] |
EFM-192A 1 | breast adenocarcinoma | invasive | na | f | 46 | PE | M | * |
EFM-192B 1 | breast adenocarcinoma | invasive | na | f | 46 | PE | M | * |
EFM-192C 1 | breast adenocarcinoma | invasive | na | f | 46 | PE | M | * |
ETCC-006 2 | breast ductal carcinoma | in situ | ductal | f | 47 | breast | P | [22] |
ETCC-007 2 | breast ductal carcinoma | in situ | ductal | f | 47 | breast | P | [22] |
EVSA-T | breast carcinoma | invasive | na | f | 58 | ascites | M | [23] |
HCC-1143 3 | breast ductal carcinoma | invasive | ductal | f | 52 | breast | P | [24] |
HCC-1599 3 | breast ductal carcinoma | invasive | ductal | f | 44 | breast | P | [24] |
HCC-1937 3 | breast ductal carcinoma | invasive | ductal | f | 24 | breast | P | [24] |
HDQ-P1 | breast ductal carcinoma | invasive | ductal | f | 50 | breast | P | [25] |
HS-578T | breast carcinosarcoma | invasive | ductal | f | 74 | breast | P | [26] |
IPH-926 | breast lobular carcinoma | invasive | lobular | f | 72 | ascites | M | [27] |
JIMT-1 | breast ductal carcinoma | invasive | ductal | f | 62 | PE | M | [28] |
KPL-1 4 | breast adenocarcinoma | invasive | na | f | 69 | PE | M | [10] |
MCF-7 | breast adenocarcinoma | invasive | na | f | 69 | PE | M | [10] |
MDA-MB-231 | breast carcinoma | invasive | na | f | 51 | PE | M | [29] |
MDA-MB-453 | breast carcinoma | invasive | na | f | 48 | PF | M | [29] |
MDA-MB-468 | breast carcinoma | invasive | na | f | 51 | PE | M | [29] |
MFM-223 | breast ductal carcinoma | invasive | ductal | f | >45 | PE | M | [30] |
SK-BR-3 | breast adenocarcinoma | invasive | na | f | 43 | PE | M | [31] |
T-47D | breast ductal carcinoma | invasive | ductal | f | 54 | PE | M | [32] |
1 Sister cell lines from same patient (A was established 14 days earlier than B and C). 2 hTERT immortalized clones from same patient. 3 Paired B lymphoblastoid cell line (B-LCL) available. 4 Derivative of MCF-7 (see DSMZ website for details). * Data provided by cell line depositor to DSMZ cell lines bank. Abbreviations: f = female, M = metastatic tumor, na = not available, P = primary tumor, PE = pleural effusion, PF = pericardial fluid.